Viewing Study NCT05983367

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-02-03 @ 9:53 AM
Study NCT ID: NCT05983367
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-04
First Post: 2023-08-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
Sponsor: Inspirna, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
None Metastatic Colon Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic colon cancer View
None KRAS colon cancer View
None CRC advance cancer View
None malignant colorectal tumor View
None RAS mutant colon cancer View